Algert Global’s St Jude Medical STJ Stock Holding History

Algert Global’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-16,420	Closed	-$749K	–	375
2013 Q2	$749K	Buy	+16,420	New	+$712K	0.23%	151

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Algert Global's STJ Position: Q3 2013 in Review

Algert Global sold out of St Jude Medical (STJ) in Q3 2013, closing a stake of 16,420 shares — an estimated $749K sold.

Algert Global first reported a position in STJ in Q2 2013 and held it in 1 quarter. The position peaked at $749K in Q2 2013. 486 funds tracked by Wall St. Rank hold STJ as of Q3 2013.

Algert Global reported no remaining St Jude Medical position as of Q3 2013 after selling out during the quarter.
Algert Global sold 16,420 St Jude Medical shares in Q3 2013, an estimated $749K.
Algert Global first reported a position in St Jude Medical in Q2 2013 and held it in 1 quarter.
Algert Global's St Jude Medical position peaked at $749K in Q2 2013.
486 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2013.

Based on Algert Global's 13F filing for Q3 2013, filed 12 Nov 2013.